Positivt for merkeva
Positivt for merkevarer
November 04, 2004 02:00 ET | Orkla ASA
Orkla hadde i tredje kvartal en vekst i driftsresultat før goodwillavskrivninger på tre prosent sammenlignet med fjoråret, til 582 mill. kr. Omsetning etter tre kvartaler var på 23,5 milliarder kr,...
Positive results for
Positive results for Branded Consumer Goods
November 04, 2004 02:00 ET | Orkla ASA
Orkla's third quarter operating profit before goodwill amortisation was up 3 % compared with last year and totalled NOK 582 million. Operating revenues at the end of the first nine months amounted to...
Basilea's First-In-Class Antibiotic Ceftobiprole (BAL5788) Moves into Phase III
November 04, 2004 01:23 ET | Basilea Pharmaceutica Ltd
BASEL, Switzerland, Nov. 4, 2004 (PRIMEZONE) -- Basilea Pharmaceutica AG announces the start of its international phase III program for ceftobiprole (BAL5788), a novel broad spectrum, first-in-class...
Basilea-Logo.jpg
Basilea startet Phase-III-Studien mit Ceftobiprol (BAL5788) - dem ersten Vertreter einer neuen Klasse von Antibiotika
November 04, 2004 01:15 ET | Basilea Pharmaceutica AG, Allschwil
Basel, 4. November 2004   Basilea Pharmaceutica AG gibt den Beginn ihres internationalen Phase-III-Programms bei komplizierten Infektionen der Haut und Weichteile, verursacht durch...
Basilea-Logo.jpg
Basilea's First-In-Class Antibiotic Ceftobiprole (BAL5788) Moves into Phase III
November 04, 2004 01:15 ET | Basilea Pharmaceutica AG, Allschwil
Basel, Switzerland, 4th November 2004   Basilea Pharmaceutica AG announces the start of its international phase III program for ceftobiprole (BAL5788), a novel broad spectrum, first-in-class...
Martin Kauer leaves Converium
November 04, 2004 01:06 ET | Converium Holding AG
ZUG, Switzerland, Nov. 04, 2004 (PRIMEZONE) -- Converium announces that Martin A. Kauer, Group CFO of Converium, intends to leave the Company effective early 2005. The Board of Directors has taken...
Credit Suisse Group
Credit Suisse Group Reports Net Income of CHF 4.7 Billion for the First Nine Months of 2004, with Net Income of CHF 1.4 Billion for the Third Quarter of 2004
November 04, 2004 00:54 ET | Credit Suisse Group
Winterthur Reaffirms Core Earnings Strength, Achieving Solid Results with Healthy Premium Growth for the First Nine Months of 2004 ZURICH, Switzerland, Nov. 04, 2004 (PRIMEZONE) -- Credit...
Allied Home Mortgage
Allied Home Mortgage Capital Corporation Retracts Nov. 2 Press Release Concerning Revocation of Temporary Restraining Order
November 03, 2004 21:09 ET | Allied Home Mortgage
HOUSTON, Nov. 3, 2004 (PRIMEZONE) -- Allied Home Mortgage Capital Corporation has retracted the press release sent out Tuesday, November 2, 2004 via the PrimeZone Media Network with the headline...
NOVARTIS logo.jpg
TEST#1 RETEST #2: Femara® gains U.S. FDA approval as only post-tamoxifen treatment for early breast cancer
November 03, 2004 18:34 ET | Novartis Pharma AG
Please find full press release under the following link:   Press Release (PDF)     Contacts   John GilardiNovartis Global Media RelationsTel +41 61 324 3018...
Drilling Commenced On Starfield Resources, Inc. Ferguson Lake Option Property
November 03, 2004 17:35 ET | Starfield Resources, Inc.
VANCOUVER, British Columbia, Nov. 3, 2004 (PRIMEZONE) -- Starfield Resources, Inc. (the Operator) (OTCBB:SRFDF) (TSX Venture Exchange:SRU) and Wyn Developments Inc. are pleased to announce that...